InforMedix Holdings, Inc., developer of the Med-e Monitor™ “smart pillbox” solution for medication adherence, is featured in the September 2007 issue of Prevention magazine. According to MediaBistro.com, Prevention is the leading healthy lifestyle magazine, and the 10th-largest magazine in the country with over 11 million readers.
The article cites the Med-eMonitor’s usefulness as an interactive pillbox in gently reminding loved ones to take their medication with a musical tone, along with warnings about potential food or drug interactions. It notes that if the individual fails to confirm that he or she has taken a dose or if anything’s amiss, their loved one is alerted by cellphone, fax or pager. The article also highlights research that shows people who use the Med-eMonitor System comply with their medication plans approximately 90 percent of the time.
InforMedix has also been recently featured in other prominent consumer and trade publications, including Popular Science (where it was selected by editors as a “must have” product and also featured on their television segment), Obesity, Fitness & Wellness, The Boston Globe, Drug Store News, Drug Week, Biotech Week and Life Science Weekly.
“This recent media coverage of the Med-eMonitor signifies consumers’ growing understanding of the common problems associated with medication non-adherence, and the worry and fear their loved ones are not properly taking their medications,” said Bruce A. Kehr, M.D., Chief Executive Officer of InforMedix. “Our Company has long recognized the health risks and hospital costs associated with medication non-compliance, and we believe recent media attention of the `smart pillbox,' in conjunction with our consumer rollout of the product, will continue to educate patients on how Med-eMonitor can improve medication adherence, safety, and peace-of-mind; and reduce the family crises resulting from unnecessary hospitalizations and nursing home admissions due to non-adherence.”
InforMedix recently launched an online store on its website (www.informedix.com) that allows consumers to purchase the Med-eMonitor.
About InforMedix
InforMedix, based in Rockville, MD, has developed the Med-eMonitor System as The Medication Adherence Solution for disease management and consumer products markets; delivering peace-of-mind to patients and their loved ones, improved independent living, and better health outcomes. InforMedix has integrated a portable patient-interactive monitoring device, hardware, software and call center monitoring to enable disease management programs, chronically ill patients and their loved ones, and medical researchers to efficiently monitor and manage patients' medication and care plan adherence, clinical response, and drug safety. To find out more about InforMedix, Inc., (OTCBB: IFMX), visit the Company website at www.informedix.com.
Safe Harbor Statement
This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy and development plans, plans for entering into new businesses, anticipated sources and uses of funds and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.